SCHEMBL5281192

SCHEMBL5281192

CCCCCN(C(=O)OC(C)(C)C)c1cccc(C(=O)OCC)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.47
RAB9A P51151 5/20 0.47
ALDH1A1 P00352 3/20 0.47
PAX8 Q06710 2/20 0.47
TP53 P04637 1/20 0.47
GPX4 P36969 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.44
CYP1A2 P05177 2/20 0.44
CYP2C9 P11712 2/20 0.44
CYP2C19 P33261 2/20 0.44
HPGD P15428 1/20 0.44
CYP4F2 P78329 1/20 0.43
CYP4A11 Q02928 1/20 0.43
JAK2 O60674 1/20 0.41
MEP1B Q16820 1/20 0.41
LMNA P02545 2/20 0.41
MAPT P10636 2/20 0.41
NPSR1 Q6W5P4 1/20 0.41
MAPK1 P28482 1/20 0.40
GAA P10253 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2494883 0.86 LMNA (0.43) NPC1RAB9AALDH1A1SMN1; SMN2CYP4F2
SCHEMBL4872329 0.82 LMNA (0.41) NPC1RAB9AALDH1A1TP53SMN1; SMN2
SCHEMBL10145149 0.81 NPC1 (0.47) NPC1RAB9AALDH1A1SMN1; SMN2CYP4F2
SCHEMBL17846085 0.79 NPC1 (0.44) NPC1RAB9AALDH1A1PAX8TP53
SCHEMBL9135663 0.78 MEP1B (0.41) NPC1RAB9AALDH1A1SMN1; SMN2CYP4F2
SCHEMBL29057034 0.76 LTB4R2 (0.45) NPC1RAB9AALDH1A1PAX8TP53
SCHEMBL30505220 0.76 LTB4R2 (0.45) NPC1RAB9AALDH1A1PAX8TP53
SCHEMBL8466175 0.76 TP53 (0.51) NPC1RAB9AALDH1A1PAX8TP53
SCHEMBL5107372 0.75 CA12 (0.42) NPC1RAB9AALDH1A1TP53SMN1; SMN2
SCHEMBL5151051 0.75 LPL (0.41) NPC1RAB9AALDH1A1PAX8TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1851208-A1 MACROCYCLIC COMPOUNDS USEFUL AS BACE INHIBITORS Novartis AG (CH) 2007-11-07 EP disclosed
WO-2006074950-A1 MACROCYCLIC COMPOUNDS USEFUL AS BACE INHIBITORS NOVARTIS AG (CH) 2006-07-20 WO disclosed